Published in Clin Exp Immunol on March 28, 2008
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature (2012) 3.63
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS (2010) 1.83
Highly active antiretroviral treatment for the prevention of HIV transmission. J Int AIDS Soc (2010) 1.51
HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J Virol (2008) 1.13
Update on animal models for HIV research. Eur J Immunol (2009) 0.89
25 years of HIV research on virology, virus restriction, immunopathogenesis, genes and vaccines. Clin Exp Immunol (2008) 0.86
Oral health associated with quality of life of people living with HIV/AIDS in Brazil. Health Qual Life Outcomes (2014) 0.82
Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives? HIV AIDS (Auckl) (2011) 0.81
Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases. Chem Cent J (2015) 0.77
Expression and activation of intracellular receptors TLR7, TLR8 and TLR9 in peripheral blood monocytes from HIV-infected patients. Colomb Med (Cali) (2013) 0.77
Microdevices for examining immunological responses of single cells to HIV. Biosci Rep (2014) 0.75
Smallest organism; highest threat. Mater Sociomed (2012) 0.75
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (1996) 26.19
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (1996) 18.53
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell (1996) 17.81
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature (2004) 17.56
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (1995) 17.42
The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (1986) 17.33
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science (1984) 15.82
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (1993) 15.54
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med (1981) 14.62
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med (2000) 11.90
Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature (2007) 11.73
Preliminary analysis of the Concorde trial. Concorde Coordinating Committee. Lancet (1993) 10.45
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (1984) 10.38
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science (1985) 9.27
Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS (2000) 8.94
Isolation of a new human retrovirus from West African patients with AIDS. Science (1986) 7.97
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell (1985) 7.86
The influence of HLA genotype on AIDS. Annu Rev Med (2001) 7.77
An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med (1981) 7.35
Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science (2006) 7.12
Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol (2005) 5.92
Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet (1984) 5.20
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis (2005) 5.14
HIV disease: fallout from a mucosal catastrophe? Nat Immunol (2006) 5.08
HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med (2004) 5.08
Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet (1985) 4.99
Human immunodeficiency viruses. Science (1986) 4.34
Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. MMWR Morb Mortal Wkly Rep (1981) 3.78
Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol (2002) 3.66
Human immunodeficiency viruses: SIV infection in wild gorillas. Nature (2006) 3.35
The Durban Declaration. Nature (2000) 2.96
How does HIV cause AIDS? Science (1993) 2.92
Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. Annu Rev Med (2008) 2.81
APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci (2007) 2.80
Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol (1999) 2.65
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet (2004) 2.54
The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology (2007) 2.54
Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science (1983) 2.48
Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet (1986) 2.48
Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet (1984) 2.43
LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur. Science (1991) 2.37
Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet (1984) 2.32
Elite control of HIV Infection: implications for vaccines and treatment. Top HIV Med (2007) 2.16
Acquired immunodeficiency syndrome in Rwanda. Lancet (1984) 2.05
The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol (2007) 2.03
Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet (1985) 2.01
Where does HIV live? N Engl J Med (2004) 1.96
Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol (2001) 1.92
HIV vaccine failure prompts Merck to halt trial. Nature (2007) 1.87
High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans. Curr Biol (2006) 1.85
Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection. PLoS Med (2006) 1.61
Parameter identifiability and estimation of HIV/AIDS dynamic models. Bull Math Biol (2008) 1.56
Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. Lancet (1984) 1.51
Origins of HIV and the evolution of resistance to AIDS. Science (2006) 1.49
Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS. Science (1983) 1.49
Prospects for an AIDS vaccine: three big questions, no easy answers. Lancet Infect Dis (2004) 1.46
Role of common human TRIM5alpha variants in HIV-1 disease progression. Retrovirology (2006) 1.46
HIV infection of non-dividing cells: a divisive problem. Retrovirology (2006) 1.33
Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. J Virol (2005) 1.31
HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet (1985) 1.25
Possible transfusion-associated acquired immune deficiency syndrome (AIDS) - California. MMWR Morb Mortal Wkly Rep (1982) 1.25
Candidate vaccines protect macaques against primate immunodeficiency viruses. AIDS Res Hum Retroviruses (1998) 1.22
HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. AIDS Res Hum Retroviruses (1998) 1.19
Male circumcision as a preventive measure against HIV and other sexually transmitted diseases. Curr Opin Infect Dis (2007) 1.18
Acquired-immunodeficiency-like syndrome in two haemophiliacs. Lancet (1983) 1.16
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest (2007) 1.06
Infection of dendritic cells by the Maedi-Visna lentivirus. J Virol (2000) 1.01
The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility. Clin Exp Immunol (2007) 0.97
Acute HIV infection: the impact of anti-retroviral treatment on cellular immune responses. Clin Exp Immunol (2007) 0.92
Dendritic cells and viruses. Immunol Lett (1988) 0.91
HLA homology within the C5 domain promotes peptide binding by HIV type 1 gp120. AIDS Res Hum Retroviruses (2008) 0.78